Elsevier

Neuropharmacology

Volume 60, Issue 1, January 2011, Pages 151-158
Neuropharmacology

Functional evidence for a twisted conformation of the NMDA receptor GluN2A subunit N-terminal domain

https://doi.org/10.1016/j.neuropharm.2010.07.003Get rights and content

Abstract

Ionotropic glutamate receptors (iGluRs) possess in their extracellular region a large N-terminal domain (NTD) that precedes the agonist-binding domain and displays a clamshell-like architecture similar to the bacterial leucine/isoleucine/valine-binding protein (LIVBP). In addition to their role in receptor assembly, in NMDA receptors (NMDARs), the NTDs of GluN2A and GluN2B subunits form a major site for subunit-specific regulation of ion channel activity, in particular through binding of allosteric modulators such as the synaptically-enriched zinc ion. A recent crystallographic study of the isolated GluN2B NTD has revealed an unexpected twisted closed-cleft conformation caused by a rotation of ∼50° in the interlobe orientation compared with all other known LIVBP-like structures (Karakas et al., 2009). By measuring currents carried by recombinant NMDARs, we now provide functional evidence, through disulfide cross-linking and the identification of a new zinc-binding residue (D283), that the GluN2A NTD of intact GluN1/GluN2A receptors adopts a similar twisted conformation in its closed-cleft state. We propose that the twisted NTD conformation is a distinct structural feature of NMDARs (at least for GluN2A and GluN2B subunits), arguing for interactions between the NTDs in the tetrameric complex that are likely to differ between NMDA and AMPA/kainate receptors.

Introduction

The vast majority of excitation in the mammalian brain and spinal cord is mediated by the amino-acid glutamate. Following neuronal activity, glutamate is released in the extracellular medium and acts on two large families of plasma membrane receptors: metabotropic glutamate receptors (mGluRs), which are G-protein coupled receptors, and iGluRs which form glutamate-gated ion channels selective for cations. The iGluR family is further divided into three subfamilies named for their selective agonists, AMPA, kainate and NMDA, with diverse functions and various genes encoding multiple receptor subunits for each subfamily (Dingledine et al., 1999).

Considerable progress has been made during the last decade regarding the molecular architecture of glutamate receptors. The combination of functional, biochemical and structural studies has established that both mGluRs and iGluRs possess in their extracellular region globular clamshell-like domains that have homology to soluble bacterial periplasmic binding proteins (PBPs) (O’Hara et al., 1993, Mayer, 2006). The extracellular region of iGluR subunits are actually made of two adjacent PBP-like domains: the N-terminal domain (NTD), which encompasses the first ∼380 amino acids and is related to LIVBP, and the agonist-binding domain (ABD) that is directly connected to the transmembrane region and that is related to the glutamine binding-protein (QBP). In the mGluR family, each subunit comprises a single extracellular clamshell-like domain that forms the glutamate-binding domain and that, similarly to the iGluR NTDs, is related to LIVBP. Crystal structures of AMPA, kainate and NMDA ABDs, (Armstrong and Gouaux, 2000, Furukawa and Gouaux, 2003, Furukawa et al., 2005, Mayer, 2005, Yao et al., 2008), and of dimeric glutamate-binding domains of mGluRs (Kunishima et al., 2000), both with and without ligands, have revealed that all these domains share with PBPs a common overall structure and mode of operation. They fold as two lobes tethered together by a hinge defining a large central interlobe cleft. The activating ligand (i.e. agonist) binds in the central cleft, promotes domain closure and stabilization of a closed-cleft conformation through a hinge-bending motion (Quiocho and Ledvina, 1996, Jingami et al., 2003, Mayer, 2006).

Structural and functional insights on iGluR NTDs were obtained more recently. These domains play a major role in subunit assembly, insuring that only subunits within a subfamily assemble with one another (Leuschner and Hoch, 1999, Meddows et al., 2001, Ayalon and Stern-Bach, 2001, Ayalon et al., 2005). As expected, the structures of AMPA and kainate NTDs, either in isolation (Kumar et al., 2009, Jin et al., 2009, Clayton et al., 2009) or in an intact tetrameric GluA2 AMPA receptor (Sobolevsky et al., 2009), show the typical LIVBP-like fold, and in agreement with their role as assembly signals, NTDs form tightly associated dimers. Intriguingly, there are no known ligands that bind the NTDs of AMPA and kainate receptors and structural constraints within the NTD dimer render conformational motions of the hinge-bending type unlikely (Kumar et al., 2009, Jin et al., 2009). The situation strikingly differs for NMDARs. Indeed, in this receptor family, the NTDs are capable of functional regulation of channel activity. By spontaneously oscillating between an open-cleft and a closed-cleft conformation, the GluN2 NTDs tune channel open probability in a subunit-specific fashion (Gielen et al., 2009; see also Yuan et al., 2009). GluN2 NTDs are also a major determinant of NMDAR pharmacology providing binding sites for small ligands that allosterically modulate ion channel activity. These ligands include ifenprodil and derivatives, a large family of synthetic compounds that selectively antagonize NMDARs containing the GluN2B subunit (Masuko et al., 1999, Perin-Dureau et al., 2002, Marinelli et al., 2007, Mony et al., 2009a, Mony et al., 2009b). The zinc ion, accumulated at many excitatory synapses in the brain (Paoletti et al., 2009), is another ligand that produce potent inhibition of NMDARs by targeting the NTDs. Zinc binds the NTD of both GluN2A and GluN2B subunits, and it is believed that zinc binding in the central cleft triggers domain closure, producing ligand-induced conformational changes similar to those observed in other LIVBP-like proteins (Paoletti et al., 2000, Rachline et al., 2005, Gielen et al., 2008).

The first NTD structure of an NMDAR, that of the GluN2B subunit, has recently been solved, providing a detailed molecular map of this important regulatory domain (Karakas et al., 2009). Unexpectedly, this domain, captured in a closed-cleft conformation, shows a distinct clamshell-like architecture, with a lobe 1/lobe 2 orientation twisted by ∼50° compared to all other LIVBP-like structures released to date. Interestingly, this twisted conformation maps previously unpredicted residues in the zinc and ifenprodil binding sites (Karakas et al., 2009). We wondered if this novel NTD twisted conformation is a peculiar property of the GluN2B NTD or if it is transferable to other NMDAR subunits, in particular to the GluN2A NTD, a domain also capable of experiencing cleft closures and openings. By engineering disulfide bridges and identifying a new residue critical for high-affinity GluN2A-specific NMDAR zinc inhibition, we provide functional evidence that the twisted closed-cleft conformation is not unique to GluN2B NTD but also applies to the GluN2A NTD.

Section snippets

Molecular biology

The pcDNA3-based expression plasmids for the rat GluN1-1a subunit (named GluN1 herein) and the rat GluN2A and mouse GluN2B subunits have been described previously (Paoletti et al., 2000, Rachline et al., 2005). Site-directed mutagenesis was performed using QuikChange (Stratagene) and the presence of the mutation was verified by DNA sequencing.

Electrophysiology

Recombinant NMDARs were expressed in Xenopus laevi oocytes after nuclear co-injection of GluN1 and GluN2 cDNAs (at 10 ng/μl each, ratio 1:1). Oocytes were

Mutating GluN2A NTD residue D283 eliminates high-affinity zinc inhibition

Zinc binding to GluN2A NTD and GluN2B NTD mediates zinc inhibition of GluN2A- and GluN2B-containing receptors, respectively. On both receptor subtypes, zinc acts in a non-competitive (allosteric) and voltage-independent manner, yet zinc is a much more potent antagonist at GluN2A-containing receptors (IC50 ∼10 nM) than at GluN2B-containing receptors (IC50 ∼1 μM) (Paoletti and Neyton, 2007). Extensive mutagenesis led to the identification of several residues of the GluN2A and GluN2B NTD interlobe

Discussion

In the present work, we provide functional evidence that the NTD of the GluN2A subunit adopts, in an intact NMDAR, an “atypical” twisted closed-cleft conformation similar to that recently seen in the high-resolution crystal structure of the isolated GluN2B NTD (Karakas et al., 2009). Because the NTD of NMDARs is critically involved in subunit assembly and subunit-specific receptor regulation (Meddows et al., 2001, Gielen et al., 2009, Yuan et al., 2009), we believe that this result has

Acknowledgements

We thank Marc Gielen and Laetitia Mony for comments on the manuscript. This work was supported by the Agence Nationale de la Recherche (ANR) and the Fondation pour la Recherche Médicale (“Equipe FRM” grant).

References (46)

  • M.L. Mayer

    Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity

    Neuron

    (2005)
  • E. Meddows et al.

    Identification of molecular determinants that are important in the assembly of N-methyl-d-aspartate receptors

    J. Biol. Chem.

    (2001)
  • P.J. O’Hara et al.

    The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins

    Neuron

    (1993)
  • P. Paoletti et al.

    NMDA receptor subunits: function and pharmacology

    Curr. Opin. Pharmacol

    (2007)
  • P. Paoletti et al.

    Molecular organization of a zinc binding N-terminal modulatory domain in a NMDA receptor subunit

    Neuron

    (2000)
  • P. Paoletti et al.

    Zinc at glutamatergic synapses

    Neuroscience

    (2009)
  • F.C. Acher et al.

    Amino acid recognition by Venus flytrap domains is encoded in an 8-residue motif

    Biopolymers

    (2005)
  • I.L. Alberts et al.

    Analysis of zinc binding sites in protein crystal structures

    Protein Sci.

    (1998)
  • A. Birdsey-Benson et al.

    Enhanced efficacy without further cleft closure: reevaluating twist as a source of agonist efficacy in AMPA receptors

    J. Neurosci.

    (2010)
  • E.J. Bjerrum et al.

    Rigid body essential X-ray crystallography: distinguishing the bend and twist of glutamate receptor ligand binding domains

    Proteins

    (2008)
  • D. Colquhoun

    Binding, gating, affinity and efficacy: the interpretation of structure–activity relationships for agonists and of the effects of mutating receptors

    Br. J. Pharmacol.

    (1998)
  • W.L. DeLano

    The PyMOL Molecular Graphics System

    (2002)
  • R. Dingledine et al.

    The glutamate receptor ion channels

    Pharmacol. Rev.

    (1999)
  • Cited by (25)

    • Molecular Basis for Subtype Specificity and High-Affinity Zinc Inhibition in the GluN1-GluN2A NMDA Receptor Amino-Terminal Domain

      2016, Neuron
      Citation Excerpt :

      Extensive mutagenesis studies in the past demonstrated that altering GluN2A-His44, GluN2A-His128, and GluN2A-Glu266, but not GluN2A-Asp282, to alanine reduces potency and efficacy of the zinc inhibition (Choi and Lipton, 1999; Fayyazuddin et al., 2000). Instead, the GluN2A-Asp283Ala mutation was shown to alleviate the high-affinity zinc inhibition, which led to the conclusion that GluN2A-Asp283 but not GluN2A-Asp282 is involved in direct zinc coordination (Stroebel et al., 2011). In order to validate our structural observation that GluN2A-Asp282 is directly involved in coordination of zinc and therefore high-affinity zinc inhibition, we mutated GluN2A-Asp282 to alanine, histidine, and glutamate and measured zinc inhibition by electrophysiology and found that site-directed mutation of GluN2A-Asp282 dramatically affected zinc inhibition in our hands (Figures 6F and 6G).

    • Structure, Dynamics, and Allosteric Potential of Ionotropic Glutamate Receptor N-Terminal Domains

      2015, Biophysical Journal
      Citation Excerpt :

      Although no cleft ligand has been identified yet for non-NMDAR NTD clefts, electron density has been observed in GluA2 (55,57) and GluK2 (60). Interlobe twisting has been described for NMDAR NTDs (70,71) and also in the GluA2 LBD, where it has been linked to partial agonist binding (77). In line with our previous ANM analysis of AMPAR and NMDAR NTDs (56), we find that both modes of motion are conserved across the iGluRs, but the extent varies (Fig. 2, C and D).

    • Allosteric modulators of NMDA receptors: Multiple sites and mechanisms

      2015, Current Opinion in Pharmacology
      Citation Excerpt :

      The NMDAR structure displays three striking features that differentiate it from the GluA2 AMPAR structure: a distinct NTD conformation and arrangement and strong interactions between the two GluN1–GluN2 ABD dimers and between the NTD and ABD layers. At the NTD level, individual domains display the typical bilobate (or clamshell) shape but with a major (50°) twist-angle between the two lobes, an unprecedented feature for clamshell-like domains ([18,19]; see also [20]). As a consequence, the GluN1 and GluN2B NTDs associate with each other mostly through upper lobe interactions leaving the lower lobe ‘free’ to move.

    • Comparative dynamics of NMDA- and AMPA-glutamate receptor n-terminal domains

      2012, Structure
      Citation Excerpt :

      The NTD of the NMDAR is known to modulate channel gating by binding Zn2+ ions and ifenprodil-like compounds, thereby sparking clinical interest in these domains. The twisted LL along with surface properties (Karakas et al., 2009; Stroebel et al., 2011) have been purported to be the primary reason why NTD-mediated modulation of the ion channel is seen in GluN2B and NMDAR heterodimers but have not been seen so far in non-NMDA receptors. Structural dynamics analysis offers a different perspective, where the global motions accessible to the different NTD structures of the iGluR families overlap remarkably.

    View all citing articles on Scopus
    View full text